MedTrace Logo

Chinese Cancer Prevention Study(CHICAPS)

NCT01524003 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8382

Last updated 2015-05-08

No results posted yet for this study

Summary

The purpose of this study is to develop and implement a community based preventive healthcare model using cervical cancer screening as the target medical intervention.

The investigators will first conduct 2 pilot studies to refine their preventive healthcare model based on the principles of community based participatory research (1000 participants). The investigators will then apply the model to screen 9000 women for cervical cancer over a period of 7-9 days. This 10,000 patient trial will explore the ability of a community to conduct their own screening program to identify who needs medical intervention based on self-collection and centralized high-throughput low cost human papillomavirus (HPV) testing.

Conditions

  • Cervical Intraepithelial Neoplasia
  • Cervical Cancer
  • Cervical Neoplasm
  • Cervical Dysplasia
  • Human Papillomavirus

Interventions

PROCEDURE

cryotherapy

cryotherapy treatment of the uterine cervix

PROCEDURE

Colposcopy

Colposcopy, biopsy and LEEP based on the pathology results

Sponsors & Collaborators

  • Peking University Shenzhen Hospital

    collaborator OTHER

  • Preventive Oncology International, Inc.

    lead OTHER

Principal Investigators

  • Jerome L Belinson, MD · Preventive Oncology International

  • Rufiang Wu, MD · Peking Universtiy Shenzhen Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
59 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2013-07-31
Completion
2014-01-31

Countries

  • China

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01524003 on ClinicalTrials.gov